Search

everythinglearnresearchcommunity

for

Search:↓

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

An 87-year-old woman was diagnosed with type 3 autoimmune polyendocrine syndrome and had multiple autoimmune issues.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

The LMNA mutation affects skin structure even in asymptomatic carriers.

Higher levels of MIG and IP-10 may help diagnose and monitor Alopecia Areata.

Early stage bald spots are linked to skin inflammation and damage to the upper part of the hair follicle.

Ischemia-modified albumin can help diagnose ischemic conditions early, but better detection methods are needed.

The MTHFR C677T mutation may increase the risk of alopecia areata in the Turkish population.

A woman had meningitis caused by mixed connective tissue disease, not an infection.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

A patient with Satoyoshi syndrome improved with a treatment combining several medications, including carbamazepine and methotrexate.

Certain genetic markers can indicate higher or lower risk for systemic lupus erythematosus.

High-throughput LC-MS screening is effective for finding new autotaxin inhibitors for asthma treatment.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.

People with alopecia areata have higher insulin resistance.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Alopecia areata and myasthenia gravis can occur as rare symptoms of breast cancer.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

The review shows that skin symptoms like chronic fungal infections, hair loss, and skin depigmentation are key for early detection and management of APECED.

Three molecular subtypes of advanced skin T-cell lymphoma were identified, with potential biomarkers for predicting treatment response and disease progression.

Antibodies help identify glycoproteins in normal skin and tumor cells.

IMTA can help regrow hair in severe alopecia areata when JAK inhibitors don't work well.

Waldenstrom’s Macroglobulinaemia can mimic multiple myeloma, so accurate diagnosis is crucial.

A new mutation in the STING protein causes a disease with lupus-like symptoms and responds well to a specific inhibitor treatment.

Alopecia areata patients often have other autoimmune diseases, especially women with nail issues or atopic diseases.

A man with hypoparathyroidism had other health issues that led to a diagnosis of a rare autoimmune disorder, APS-1.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Chronic refractory alopecia areata has more skin-resident memory T cells, and JAK inhibitors may help reduce them.